• a
  • a
  • a
  • Adjust text size

Rosacea Review - Newsletter of the National Rosacea Society

Medical Scientists Report Advances During Rosacea Research Workshop

Medical scientists reported significant progress in exploring the potential causes and other key aspects of rosacea during a recent research workshop organized by the National Rosacea Society.

The session was attended by more than 70 researchers, and was held for the second year during the annual meeting of the Society for Investigative Dermatology to review ongoing studies funded by grants from the National Rosacea Society and to foster increased scientific interest in rosacea research.

"The generous support of rosacea sufferers in funding research is now beginning to bring important new insights into this chronic and little-known disorder," said Dr. Frank Powell of Mater Misericordiae Hospital in Dublin, Ireland, and a leading rosacea researcher. "Because current therapy is limited to controlling symptoms, identifying the cause or causes of rosacea is a fundamental step that should not only help improve treatment, but may ultimately lead to its cure or prevention." The National Rosacea Society's research grants program is funded by individual donations, and readers are encouraged to send tax-deductible contributions using the Donation Form.

Dr. Marita Kosmadaki, a research fellow in the Department of Dermatology, Boston University, reported interim results of the study, "The role of vascular endothelial growth factor (VEGF) in rosacea development," now in its second year of funding by the Society. Based on study results the first year, Dr. Kosmadaki and colleagues concluded that the effects of the sun on VEGF, a natural substance in the body that has a potent effect on blood vessels, may lead to persistent redness and the development of telangiectasia (visible blood vessels).

This year, the researchers noted that TNF alpha, a substance that makes the skin more receptive to VEGF, was stimulated by the sun, and they are now studying whether blocking TNF alpha may inhibit rosacea development.

Dr. Ethan Lerner, associate professor of dermatology at Harvard Medical School, is studying whether nitric oxide, a potent dilator of blood vessels, may play a role in rosacea. During his study, microscopic views of mice -- bred to have high levels of nitric oxide in their skin -- have shown inflammation around the hair follicles, a hallmark of rosacea.

Dr. Lerner is now examining skin samples from patients with mild rosacea for the presence of nitric oxide, and is applying an agent to inhibit the enzyme that makes nitric oxide. Results, however, were too early to be definitive, he said.

Dr. Powell reported that he and colleague Dr. Kevin Kavanagh of the National University of Ireland, Maynooth found that Demodex mites, microscopic organisms found in all human skin, were far more numerous on the faces of rosacea patients than in a normal control group. They are now in the process of identifying bacteria from the mite that may be a factor in rosacea.

Dr. Mark Dahl of the Mayo Clinic - Scottsdale presented a completed study on the relationship of rosacea and skin temperature, reported in detail in the article New Study Links Warmer Skin to Rosacea Bumps and Pimples.

 

Issue:

Issues

Contact Us

Phone:
1-888-NO-BLUSH
Email:
rosaceas@aol.com
National Rosacea Society
196 James St.
Barrington, IL 60010

Our Mission

The National Rosacea Society is a 501(c)(3) nonprofit organization whose mission is to improve the lives of people with rosacea by raising awareness, providing public health information and supporting medical research on this widespread but little-known disorder. The information the Society provides should not be considered medical advice, nor is it intended to replace

consultation with a qualified physician. The Society does not evaluate, endorse or recommend any particular medications, products, equipment or treatments. Rosacea may vary substantially from one patient to another, and treatment must be tailored by a physician for each individual case. For more information, visit About Us.